SCHEMBL30060464

SCHEMBL30060464

Fc1cc(-c2ncc(CNc3cc(-c4cn[nH]c4)nc(C(F)(F)F)c3)cn2)ccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.38
▸ TP53 P04637 6/20 0.38
▸ ADORA2A P29274 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ SMN1; SMN2 Q16637 5/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ ROCK2 O75116 2/20 0.35
▸ PPARA Q07869 1/20 0.34
▸ ROCK1 Q13464 1/20 0.34
▸ DYRK1A Q13627 1/20 0.33
▸ CLK4 Q9HAZ1 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ PDE4D Q08499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23611372 1.00 MAPT (0.38) MAPTTP53ADORA2ATDP1SMN1; SMN2
SCHEMBL23611448 0.93 CLK1 (0.37) MAPTTP53ADORA2ATDP1SMN1; SMN2
SCHEMBL30060447 0.93 CLK1 (0.37) MAPTTP53ADORA2ATDP1SMN1; SMN2
SCHEMBL30060445 0.89 MAPT (0.44) MAPTTP53ADORA2ATDP1SMN1; SMN2
SCHEMBL23611386 0.89 MAPT (0.44) MAPTTP53ADORA2ATDP1SMN1; SMN2
SCHEMBL23611335 0.88 VNN1 (0.35) MAPTTP53ADORA2ATDP1SMN1; SMN2
SCHEMBL30060452 0.88 VNN1 (0.35) MAPTTP53ADORA2ATDP1SMN1; SMN2
SCHEMBL23611312 0.85 CYP2C9 (0.39) MAPTTP53ADORA2ATDP1SMN1; SMN2
SCHEMBL30060466 0.85 CYP2C9 (0.39) MAPTTP53ADORA2ATDP1SMN1; SMN2
SCHEMBL23611347 0.85 VNN1 (0.35) MAPTTP53ADORA2ATDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085057-A1 NOVEL PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
Send feedback